Celldex Therapeutics shares owned by Pnc Financial Services
Quarter-by-quarter ownership of Celldex Therapeutics (CLDX) shares owned by Pnc Financial Services
from 13F filings
Historical chart of Pnc Financial Services investment in Celldex Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Celldex Therapeutics held by Pnc Financial Services consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Celldex Therapeutics by Pnc Financial Services
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $17k | 392 | 41.97 |
| 2023-12-31 | $17k | 425 | 39.66 |
| 2023-09-30 | $11k | 392 | 27.52 |
| 2023-06-30 | $27k | 780 | 33.93 |
| 2023-03-31 | $17k | 484 | 35.98 |
| 2022-12-31 | $22k | 484 | 44.57 |
| 2022-09-30 | $2.0k | 87 | 22.99 |
| 2022-06-30 | $3.0k | 100 | 30.00 |
| 2020-12-31 | $18k | 1.0k | 18.00 |
| 2020-09-30 | $15k | 1.0k | 15.00 |
| 2019-09-30 | $0 | 79 | 0.00 |
| 2019-06-30 | $0 | 79 | 0.00 |
| 2019-03-31 | $0 | 79 | 0.00 |